The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

A craniotomy may be needed to treat brain tumors, aneurysms, epilepsy, or vascular malformations when other treatments are not effective.

The Urine Culture and Sensitivity (Urine C/S) test detects bacteria in the urine and determines the most effective antibiotics for treatment.

A urine sample is collected using the midstream clean-catch technique and sent to the laboratory for culture and sensitivity testing.

It helps diagnose urinary tract infections (UTIs) and guides healthcare providers in prescribing appropriate antibiotics.

Results are typically available within 3 to 5 days, depending on the growth and sensitivity testing required.

Yes, fasting is not required. However, follow specific instructions provided by your healthcare provider for sample collection.